Menu
It is the second most common cancer in gynaecological oncology, accounting for between 4% and 5% of female tumours.
It originates from the malignant transformation of the cells that cover the female reproductive system (ovary and tubes). This type of cancer is diagnosed in more than 60% of cases in advanced stages, as early diagnosis, although critical, is difficult.
It usually occurs between the ages of 45 and 75. There is no known risk factor directly associated with it, but it is related to circumstances such as age (it is not common before the age of 40) or motherhood (women who have not had children are more likely to suffer from it).
Some symptoms that help to detect it are abdominal swelling due to fluid accumulation, which may come with discomfort in the lower abdomen, the presence of lumps or bumps in the lower abdomen, severe weight loss and, sometimes, the presence of vaginal bleeding between menstrual cycles or in menopausal women.
The IVO has a medical service specialising in gynaecology that treats all oncological conditions related to the female reproductive system, covering the diagnosis, treatment and follow-up of its patients.
The Gynaecological Tumour Committee is made up of a multidisciplinary team of expert professionals.
The IVO gynaecology service attends to women with gynaecological cancers.
A clinical trial is a research study carried out on people with the aim of learning more about how the body reacts to certain treatments. These trials generally seek to find drugs that are more effective than the current best therapeutic option for patients, or that have similar efficacy but a better toxicity profile.
Bearing in mind that almost all currently available treatments are the result of clinical research, the importance of clinical trials is obvious.
The IVO has a clinical trials unit for all types of tumours and participates in phase 1-3 studies as well as other types of studies.
Whether you receive the news of an initial diagnosis of cancer or a relapse, coping with cancer can be emotionally overwhelming. Each person has their own way of coping with an ovarian cancer diagnosis, but there are some recommendations that can help you through this process:
© 2022 IVO Fundación Instituto Valenciano de Oncología